Could CT screening for lung cancer ever be cost effective in the United Kingdom ?
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in Cost Effectiveness and Resource Allocation
- Vol. 6 (1) , 5
- https://doi.org/10.1186/1478-7547-6-5
Abstract
The absence of trial evidence makes it impossible to determine whether or not mass screening for lung cancer would be cost effective and, indeed, whether a clinical trial to investigate the problem would be justified. Attempts have been made to resolve this issue by modelling, although the complex models developed to date have required more real-world data than are currently available. Being founded on unsubstantiated assumptions, they have produced estimates with wide confidence intervals and of uncertain relevance to the United Kingdom.Keywords
This publication has 60 references indexed in Scilit:
- Screening using whole-body magnetic resonance imaging scanning: who wants an incidentaloma?Journal of Medical Screening, 2007
- Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for anotherCurrent Medical Research and Opinion, 2007
- Lung Cancer Screening Results: Easily MisunderstoodMayo Clinic Proceedings, 2007
- Clinical Features of 5,628 Primary Lung Cancer PatientsChest, 2005
- The Cost-Effectiveness of Low-Dose CT Screening for Lung Cancer*Chest, 2003
- CT screening: a trade-off of risks, benefits, and costsJournal of Clinical Investigation, 2003
- Lung cancer screening by low-dose spiral computed tomographyEuropean Respiratory Journal, 2001
- Treatment pathways, resource use and costs in the management of small cell lung cancerThorax, 2001
- Economic decision analysis model of screening for lung cancerEuropean Journal Of Cancer, 2001
- Smoking and Cancer Screening for Women Ages 42–75: Associations in the 1990–1994 National Health Interview SurveysPreventive Medicine, 1999